Logilet (uk) Limited secures £151.2k for DNA detection technology

Advanced diagnostic technology is the focus of Logilet (uk) Limited, which recently secured an estimated £151.2k in funding. The company develops point-of-care DNA detection platforms that utilize digital microfluidics and real-time PCR. The enterprise designed these systems to improve the speed and accuracy of clinical testing.

The firm, which was incorporated in 2024, offers the Logicore system for molecular syndromic infectious disease testing. The business provides specific panels designed to detect potential respiratory pathogens and various sexually transmitted infections. These solutions aim to streamline the complex processes typically associated with high precision screening.

Based in London, the company documented this latest funding round in public filings during September 2026. This followed a share allotment that took place in June 2026. Financial records show that the most recent accounting period for the entity ended on 31 December 2025. No specific revenue or profit figures were included in the latest available filings.